
Paul Martens Janeski
Examiner (ID: 4040, Phone: (571)270-1681 , Office: P/3722 )
| Most Active Art Unit | 3722 |
| Art Unit(s) | 3726, 3722 |
| Total Applications | 635 |
| Issued Applications | 463 |
| Pending Applications | 0 |
| Abandoned Applications | 175 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16375059
[patent_doc_number] => 20200323901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => Mutant Bordetella Strains and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 16/863972
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863972 | Mutant | Apr 29, 2020 | Issued |
Array
(
[id] => 17633881
[patent_doc_number] => 11344586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment
[patent_app_type] => utility
[patent_app_number] => 16/854117
[patent_app_country] => US
[patent_app_date] => 2020-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 115
[patent_no_of_words] => 22540
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854117
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/854117 | Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment | Apr 20, 2020 | Issued |
Array
(
[id] => 16220527
[patent_doc_number] => 20200245643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => COMPOSITIONS AND METHODS OF DECREASING FEED CONVERSION RATIOS IN FOWL
[patent_app_type] => utility
[patent_app_number] => 16/853351
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853351
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853351 | Compositions and methods of decreasing feed conversion ratios in fowl | Apr 19, 2020 | Issued |
Array
(
[id] => 17168822
[patent_doc_number] => 20210322492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => PROBIOTIC STRAINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/850415
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850415 | PROBIOTIC STRAINS AND USES THEREOF | Apr 15, 2020 | Abandoned |
Array
(
[id] => 17689363
[patent_doc_number] => 20220196656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => DIAGNOSTIC REAGENTS
[patent_app_type] => utility
[patent_app_number] => 17/602628
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602628
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602628 | DIAGNOSTIC REAGENTS | Apr 8, 2020 | Pending |
Array
(
[id] => 16435748
[patent_doc_number] => 20200353073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/822403
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16822403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/822403 | Methods of producing bioconjugates of | Mar 17, 2020 | Issued |
Array
(
[id] => 16341689
[patent_doc_number] => 20200306339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => TREATMENT AND DIAGNOSIS OF INFLAMMATORY DISORDERS AND HIV
[patent_app_type] => utility
[patent_app_number] => 16/811721
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811721
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/811721 | Treatment and diagnosis of inflammatory disorders and HIV | Mar 5, 2020 | Issued |
Array
(
[id] => 16878002
[patent_doc_number] => 11028135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/804020
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 66
[patent_no_of_words] => 16311
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16804020
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/804020 | None | Feb 27, 2020 | Issued |
Array
(
[id] => 17065864
[patent_doc_number] => 20210268079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => ANTI-VENOM VACCINE
[patent_app_type] => utility
[patent_app_number] => 16/803953
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16803953
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/803953 | Anti-venom vaccine | Feb 26, 2020 | Issued |
Array
(
[id] => 16362433
[patent_doc_number] => 20200319184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES
[patent_app_type] => utility
[patent_app_number] => 16/799113
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799113
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/799113 | Vitro potency assay for protein-based meningococcal vaccines | Feb 23, 2020 | Issued |
Array
(
[id] => 16152151
[patent_doc_number] => 20200214308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => BIFIDOBACTERIUM LONGUM NCIMB 41676
[patent_app_type] => utility
[patent_app_number] => 16/794019
[patent_app_country] => US
[patent_app_date] => 2020-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16794019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/794019 | None | Feb 17, 2020 | Issued |
Array
(
[id] => 15993423
[patent_doc_number] => 20200172582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => LACTOBACILLUS ACIDOPHILUS SURFACE LAYER PROTEIN A (SLPA) AS A THERAPEUTIC AGENT FOR THE TREATMENT OF INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/790793
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790793
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790793 | None | Feb 13, 2020 | Issued |
Array
(
[id] => 17546731
[patent_doc_number] => 20220118072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/428487
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428487
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428487 | NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF | Feb 6, 2020 | Abandoned |
Array
(
[id] => 18050671
[patent_doc_number] => 11524038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Methods for treating sarcopenia and maintaining or increasing muscle mass and muscle strength in elder subjects
[patent_app_type] => utility
[patent_app_number] => 16/652740
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3333
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652740
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652740 | Methods for treating sarcopenia and maintaining or increasing muscle mass and muscle strength in elder subjects | Jan 15, 2020 | Issued |
Array
(
[id] => 15863059
[patent_doc_number] => 20200138933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/736619
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33639
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16736619
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/736619 | Immunogenic compositions for the prevention and treatment of meningococcal disease | Jan 6, 2020 | Issued |
Array
(
[id] => 16492377
[patent_doc_number] => 10858402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Synthetic multiphase systems
[patent_app_type] => utility
[patent_app_number] => 16/736505
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 63
[patent_no_of_words] => 23971
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16736505
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/736505 | Synthetic multiphase systems | Jan 6, 2020 | Issued |
Array
(
[id] => 17441851
[patent_doc_number] => 20220062356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING INCONTINENCE, OVERACTIVE BLADDER, OR MENSTRUAL CRAMPING
[patent_app_type] => utility
[patent_app_number] => 17/415020
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415020 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING INCONTINENCE, OVERACTIVE BLADDER, OR MENSTRUAL CRAMPING | Dec 19, 2019 | Abandoned |
Array
(
[id] => 15863057
[patent_doc_number] => 20200138932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => Regimens for Immunisation With Meningococcal Conjugates
[patent_app_type] => utility
[patent_app_number] => 16/716638
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16716638
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/716638 | Regimens for immunisation with meningococcal conjugates | Dec 16, 2019 | Issued |
Array
(
[id] => 16009323
[patent_doc_number] => 20200179504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => IMMUNOGENIC COMPOSITION FOR USE IN VACCINATION AGAINST STAPHYLOCOCCI
[patent_app_type] => utility
[patent_app_number] => 16/716352
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16716352
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/716352 | IMMUNOGENIC COMPOSITION FOR USE IN VACCINATION AGAINST STAPHYLOCOCCI | Dec 15, 2019 | Abandoned |
Array
(
[id] => 17649683
[patent_doc_number] => 11352397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Genetic reprogramming of bacterial biofilms
[patent_app_type] => utility
[patent_app_number] => 16/713368
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 88
[patent_no_of_words] => 35357
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713368
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/713368 | Genetic reprogramming of bacterial biofilms | Dec 12, 2019 | Issued |